Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 152

Sort by

Sort Order Select

Journal Articles

Genetic predisposition to MDS: diagnosis and management

Elissa Furutani, Akiko Shimamura

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 110–119.

https://doi.org/10.1182/hematology.2019000021

Published: 2019

Journal Articles

What's new in the prevention and treatment of cancer-associated thrombosis?

Miriam Kimpton, Marc Carrier

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 158–166.

https://doi.org/10.1182/hematology.2019000023

Published: 2019

Journal Articles

Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models

Yohei Hisada, Nigel Mackman

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 182–186.

https://doi.org/10.1182/hematology.2019000025

Published: 2019

Journal Articles

Is there a role for low-dose DOACs as prophylaxis?

Alexander T. Cohen, Beverley J. Hunt

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 187–193.

https://doi.org/10.1182/hematology.2019000026

Published: 2019

Journal Articles

Single-agent and combination biologics in acute myeloid leukemia

Guillaume Richard-Carpentier, Courtney D. DiNardo

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 548–556.

https://doi.org/10.1182/hematology.2019000059

Published: 2019

Journal Articles

Inflammatory bone marrow microenvironment

Nils B. Leimkühler, Rebekka K. Schneider

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 294–302.

https://doi.org/10.1182/hematology.2019000045

Published: 2019

Journal Articles

Common variable immune deficiency: case studies

Charlotte Cunningham-Rundles

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 449–456.

https://doi.org/10.1182/hematology.2019002062

Published: 2019

Journal Articles

Update from the clinic: what’s new in the diagnosis of cancer-associated thrombosis?

Erica A. Peterson, Agnes Y. Y. Lee

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 167–174.

https://doi.org/10.1182/hematology.2019000024

Published: 2019

Journal Articles

Microbiota modification in hematology: still at the bench or ready for the bedside?

Christopher J. Severyn, Ryan Brewster, Tessa M. Andermann

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 303–314.

https://doi.org/10.1182/hematology.2019000365

Published: 2019

Journal Articles

Clonal dynamics in chronic lymphocytic leukemia

Catherine Gutierrez, Catherine J. Wu

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 466–475.

https://doi.org/10.1182/hematology.2019000367

Published: 2019

Journal Articles

Moving immunotherapy into the front line in ALL

Amanda Winters, Lia Gore

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 209–217.

https://doi.org/10.1182/hematology.2019000017

Published: 2019

Journal Articles

Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy

Hanny Al-Samkari, Jean M. Connors

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 71–79.

https://doi.org/10.1182/hematology.2019000369

Published: 2019

Journal Articles

Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin

Katsue Suzuki-Inoue

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 175–181.

https://doi.org/10.1182/hematology.2019001388

Published: 2019

Journal Articles

Long-term complications in adolescent and young adult leukemia survivors

K. Scott Baker, Karen L. Syrjala

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 146–153.

https://doi.org/10.1182/asheducation-2018.1.146

Published: 2018

Journal Articles

Adolescent angst: enrollment on clinical trials

Theresa H. M. Keegan, Helen M. Parsons

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 154–160.

https://doi.org/10.1182/asheducation-2018.1.154

Published: 2018

Journal Articles

Breadth of complications of long-term oral anticoagulant care

Walter Ageno, Marco Donadini

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 432–438.

https://doi.org/10.1182/asheducation-2018.1.432

Published: 2018

Journal Articles

Challenges and implications of genomics for T-cell lymphomas

Eric D. Jacobsen, David M. Weinstock

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 63–68.

https://doi.org/10.1182/asheducation-2018.1.63

Published: 2018

Journal Articles

Direct oral anticoagulants: now also for prevention and treatment of cancer-associated venous thromboembolism?

Ingrid Pabinger, Julia Riedl

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 136–143.

https://doi.org/10.1182/asheducation-2017.1.136

Published: 2017

Journal Articles

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Stephen M. Ansell

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 618–621.

https://doi.org/10.1182/asheducation-2017.1.618

Published: 2017

Journal Articles

Pediatric leukemia susceptibility disorders: manifestations and management

Lisa J. McReynolds, Sharon A. Savage

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 242–250.

https://doi.org/10.1182/asheducation-2017.1.242

Published: 2017

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Genetic predisposition to MDS: diagnosis and management

What's new in the prevention and treatment of cancer-associated thrombosis?

Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models

Is there a role for low-dose DOACs as prophylaxis?

Single-agent and combination biologics in acute myeloid leukemia

Inflammatory bone marrow microenvironment

Common variable immune deficiency: case studies

Update from the clinic: what’s new in the diagnosis of cancer-associated thrombosis?

Microbiota modification in hematology: still at the bench or ready for the bedside?

Clonal dynamics in chronic lymphocytic leukemia

Moving immunotherapy into the front line in ALL

Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy

Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin

Long-term complications in adolescent and young adult leukemia survivors

Adolescent angst: enrollment on clinical trials

Breadth of complications of long-term oral anticoagulant care

Challenges and implications of genomics for T-cell lymphomas

Direct oral anticoagulants: now also for prevention and treatment of cancer-associated venous thromboembolism?

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Pediatric leukemia susceptibility disorders: manifestations and management

ASH Publications

American Society of Hematology